TipRanks
Go Ultimate55% OFF

Compare Orphazyme (1TB0) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1TB0OrphazymeEUR 80.00EUR 4.38M18.43-31.33%―Unlock the DE:1TB0 analyst price target with TipRanks PremiumDE:1TB0Unlock the DE:1TB0 top-analyst price target with TipRanks Premium
OZYMFOrphazyme$90.00$4.90M18.430.00%―Unlock the OZYMF analyst price target with TipRanks PremiumDE:1TB0 vs OZYMFUnlock the OZYMF top-analyst price target with TipRanks Premium
ACHVAchieve Life Sciences$6.48$702.82M-4.2629.10%Strong BuyUnlock the ACHV analyst price target with TipRanks PremiumDE:1TB0 vs ACHVUnlock the ACHV top-analyst price target with TipRanks Premium
AVTXAvalo Therapeutics$7.10$384.53M-1.54-59.40%Moderate BuyUnlock the AVTX analyst price target with TipRanks PremiumDE:1TB0 vs AVTXUnlock the AVTX top-analyst price target with TipRanks Premium
CRBPCorbus Pharmaceuticals$3.90$81.62M-0.60-67.78%Strong BuyUnlock the CRBP analyst price target with TipRanks PremiumDE:1TB0 vs CRBPUnlock the CRBP top-analyst price target with TipRanks Premium
GNPXGenprex$2.30$1.84M-0.01-98.24%―Unlock the GNPX analyst price target with TipRanks PremiumDE:1TB0 vs GNPXUnlock the GNPX top-analyst price target with TipRanks Premium
IRDOpus Genetics$3.64$305.33M-2.9160.87%Strong BuyUnlock the IRD analyst price target with TipRanks PremiumDE:1TB0 vs IRDUnlock the IRD top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1TB0Orphazyme80.00-36.00-31.03%
OZYMFOrphazyme90.000.000.00%
ACHVAchieve Life Sciences6.611.5029.35%
AVTXAvalo Therapeutics7.32-9.35-56.09%
CRBPCorbus Pharmaceuticals3.92-8.39-68.17%
GNPXGenprex2.23-114.37-98.09%
IRDOpus Genetics3.701.5672.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts